ATP2A3

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA007180

Antibody CAB010882

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Malignant tissues generally displayed moderate cytoplasmic staining. Most gliomas, testicular and renal cancers and many cases of prostate cancers were negative. In liver cancers, additional nucleolar staining was observed.A majority of malignancies showed weak to moderate cytoplasmic and/or membranous staining. Several malignant gliomas, prostate and renal cancers were weakly stained or negative.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected